Dong et al.22 carried out a study on atherosclerosis and found that blocking the PDGF-PDGFR signaling pathway with the tyrosine kinase inhibitor, AG1296, can reduce MMP-2 and MMP-9 expression in atherosclerotic plaques in mice. Here, MMP9 is linked to atherosclerosis.